All In Biotech

Drug Trial Radar · NCT04457856

A Study of TJ003234 in Rheumatoid Arthritis Patients

A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose and Multiple Ascending Doses of TJ003234 in Rheumatoid Arthritis Patients

Last checked: Nov 19, 2026Latest source record: Aug 3, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

63

Planned (sponsor's estimate)

Start

Aug 6, 2020

Primary completion

Mar 2023

Study completion Mar 2023

Sponsor

Lead sponsor
I-Mab Biopharma US LimitedIndustry
Sponsor type
Industry
First posted
Jul 7, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Study Purpose and Design: A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose and Multiple Ascending Doses of TJ003234 in Rheumatoid Arthritis Patients.

Conditions

  • Rheumatoid Arthritis

Interventions

  • TJ003234 injectionBiological

    Intravenous administration, single dose (0.3-1-3-10mg/kg) or multiple dose (1-3-6mg/kg, once every week, for 8 weeks)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of subject with adverse events(AEs)Time frame: First dose up to last follow-up visit (i.e. 90 days after dosing for single dose part, 140 days after first dose for multiple dose part)

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • The first affiliated hospital of bengbu medical college

    Bengbu, Anhui, China · Recruiting

  • Peking university people's Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Nanjing Drum Tower Hospital

    Nanjing, Jiangsu, China · Recruiting

  • Zhongda Hospital southeast university

    Nanjing, Jiangsu, China · Recruiting

  • FuDan University shanghai huashan Hospital

    Shanghai, Shanghai Municipality, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.